Description
The Glioma Panel 1 test, also known as the Glioma Prognostic Panel, is a molecular test used to assess the genetic makeup of gliomas, a type of brain tumor. This panel typically includes testing for IDH1/2 mutations, MGMT promoter methylation, and 1p/19q co-deletion, which are important prognostic and predictive markers in glioma.
Reviews
There are no reviews yet.